![](https://investorshub.advfn.com/uicon/596914.png?cb=1541612049)
Monday, June 17, 2019 1:13:54 PM
Currently any of the top topical CBD Brands are in CVS, Kroger's, Et.Al.. What will be telling, in time, is when the supplements and edibles hit the shelves. I believe this is where the top selling brands will differentiate; Do these same topical companies have toxicology and safety reports on their products. Who has/is doing testing on their products currently? Who has published test results? Who will be able to publish toxicology and safety results on their supplements and edibles? Given that the matrix of formulations between the various manufacturers, I doubt it would be possible for one company to piggy back off of another company's results.
Granted, of all applicants to present at the FDA hearing, CVSI was one of the few CBD plays (3??) to be granted presentation time at the hearings. But more important than being in attendance, or that Dr. Mackay received incredible support from the audience for his statements via the applause received, is what could be learned from the FDA hearing, not only from the presentations by attendees, but from the questions the FDA panel asked. Those questions were extremely telling. CVSI, because of decisions management made a few years back, bringing in tuart Tomc, and then Dr. Mackay, knew what to expect from the FDA with regard to the supplement industry. They were the only ones prepared to submit toxicology and safety reports on their products that day. Today they have additional studies which will allow them to place intended use on their labels and defend that statement with the FDA. IMHO other companies will not be able to piggy back off the CVSI testing. Reasoning- most food items are a pure ingredient, and once GRAS is received, it is acceptable for all manufacturers to use that specific ingredient in food items. Isolate will not be allowed in a food item, that is already known. Supplements are viewed differently by the FDA and require constant testing of each ingredient in the formulation. A supplement on the shelf is not only an ingredient, but also a manufacturing process as well as a formulation of final product. CVSI has studies on their final product, IMHO, so this will preclude others from piggybacking off their studies.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 02:36:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:21:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:32:15 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM